Navigation Links
ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
Date:11/6/2008

Conference call scheduled for November 6, 2008 at 1:30 p.m. (Pacific Time);

simultaneous webcast at http://www.adventrx.com

SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer, today reported financial results for the three-month and nine-month periods ended September 30, 2008.

"We recently restructured the company to curtail spending while allowing us to continue to advance our lead product candidates towards commercialization," stated Mark Bagnall, the Company's Executive Vice President and Chief Financial Officer. "We believe the market is undervaluing ANX-530 and ANX-514, both of which have the potential to generate revenues in 2010."

Three-Month Period Ended September 30, 2008 Operating Results

ADVENTRX's net loss was $6.8 million, or $0.08 per share, for the three-month period ended September 30, 2008, compared to a net loss of $5.9 million, or $0.07 per share, for the same period in 2007. Included in the net loss for the three-month period ended September 30, 2008 were non-cash, share-based compensation expenses amounting to $0.4 million, compared to $0.7 million for the same period in 2007.

Research and development, or R&D, expenses increased by $0.3 million, or 7%, to $4.7 million for the three-month period ended September 30, 2008, from $4.4 million for the same period a year ago. The increase was primarily due to a $1.7 million increase in expenses related to external research-related manufacturing and regulatory and quality assurance activit
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Announces Consolidation of Clinical and Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... mechanical engineering at the University of Texas at Dallas, ... North Texas section of the American Society of Mechanical ... in 158 countries who develop engineering standards and training. ... benefiting the world. , ASME recognized Baughn earlier this ... banquet. Baughn retired as an engineering fellow in 2012 ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 CTD Holdings, ... the pharmaceutical, medical device, cosmetics, and other markets, announced ... with a group of qualified private investors led by ... , The transaction involved the signing of ... 1,725,000 shares of Common Stock at a price per ...
(Date:7/22/2014)... 2014 The DNA Spectrum ... visual representation of history, migration, and culture. , ... by family history stories stemming from Europe. His father ... country." Pictures and 8mm home movies painted an elaborate ... family, and Steve ordered a test from DNA Spectrum ...
(Date:7/22/2014)...  Neogen Corporation (NASDAQ: NEOG ) announced ... ended May 31, increased 19% from the previous year ... to the prior year,s $27,190,000. Adjusted for a 3-for-2 ... in the current year were $0.76, compared to $0.75 ... the 2014 fiscal year established new all-time highs for ...
Breaking Biology Technology:UT Dallas professor receives Engineer of the Year award 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8
... Analysts are ... only 308 job cuts announced in the pharmaceutical industry in March, 27,000 new health care ... be correct. , ... -- If the absence of bad news can be considered good news, then it is good ...
... Encyclopedia ... Amazon.com , ... (PRWEB) April 15, 2010 -- The preponderance of autism research shows no correlation between vaccines ... encyK Resource for Parents & Professionals . By retracting the article that first reported the ...
... , ... by Behavioral HealthCare Program to streamline data reporting and ad hoc analysis , ... (PRWEB) April 13, 2010 ... utilizes a complex relational database for storing its data. The program manages behavioral ...
Cached Biology Technology:The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs 2The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs 3Research in Autism Encyclopedia Shows No Link to Children With Autism, Supports Lancet Retraction 2Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc. 2
(Date:7/22/2014)... a cost-effectiveness analysis of commercial diet programs and pills, ... the best value for the money. The Jenny Craig ... the most expensive option tested, according to researchers at ... The findings, published in the June issue of the ... health and weight-loss benefits per dollar spent as insurance ...
(Date:7/22/2014)... MSN, APRN, PMHCNS-BC, CNE, Assistant Professor of Clinical ... School of Nursing, contributed samples used in a ... with schizophrenia and also suggesting a possible link ... Biological insights from 108 schizophrenia-associated genetic loci, was ... , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
(Date:7/22/2014)... 22, 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric ... announces its next generation smart wallet, Wocket™, will be featured ... show that airs on the History Channel, FYI ... regularly features top technology products and services. The ... History Channel (6:00-6:30am ET/PT) and the FYI Network ...
Breaking Biology News(10 mins):Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3
... Indiana University study found that strengthening inspiratory muscles by ... the amount of oxygen these same breathing muscles required ... muscles. Louise Turner, a researcher in the Department ... an endurance activity, such as running, swimming or cycling ...
... to all living things can make hibernating marmots hungry ... obesity and eating disorders, according to a new study ... appears in the current issue of the Journal ... at http://jeb.biologists.org/cgi/reprint/213/12/2031 . Professor Greg Florant discovered ...
... dish coating could overcome a major challenge to the ... of Michigan researchers. Under today,s regulations, current stem ... the cells have been grown on animal-based substances that ... components create issues with the FDA (the U.S. Food ...
Cached Biology News:Inspiratory muscle training and endurance sport performance 2Marmots can teach us about obesity 2New culture dish could advance human embryonic stem cell research 2
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
Request Info...
SCP-1 (P-17)...
Biology Products: